Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - Tyrosine ratio of their associations with trait aggression

Pteridines

Volumn 27, Issue 3-4, 2016, Pages 77-85

  Mathai, Ashwin Jacob ^a,b   Lowry, Christopher A ^c,d,e,f   Cook, Thomas B ^g   Brenner, Lisa A ^d,e,h   Brundin, Lena ⁱ   Groer, Maureen W ^j   Peng, Xiaoqing ^a,b   Giegling, Ina ^k   Hartmann, Annette M ^k   Konte, Bettina ^k   Friedl, Marion ^k   Fuchs, Dietmar ^l   Rujescu, Dan ^k   Postolache, Teodor T ^a,d,e,m  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b St Elizabeths Hospital   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d Mental Illness Research Education and Clinical Center   (United States)

^e Military and Veteran Microbiome Consortium of Research and Education (MVM CORE)   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g MERCYHURST COLLEGE   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ VAN ANDEL RESEARCH INSTITUTE   (United States)

^j UNIVERSITY OF SOUTH FLORIDA   (United States)

^k MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^l INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^m VISN 5 Mental Illness Research Education and Clinical Center   (United States)

more..

Author keywords

aggressive personality traits; phenylalanine; seropositivity; Toxoplasma gondii; tyrosine

Indexed keywords

IMMUNOGLOBULIN G; PHENYLALANINE; TYROSINE;

ADULT; AGE; AGGRESSION; AMINO ACID BLOOD LEVEL; ARTICLE; BEHAVIOR ASSESSMENT; BUSS DURKEE HOSTILITY QUESTIONNAIRE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SEROPREVALENCE; SEX DIFFERENCE; TOXOPLASMA GONDII;

EID: 85002323867     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pterid-2016-0006     Document Type: Article

References (101)

1. Cook TB, Brenner LA, Cloninger CR, Langenberg P, Igbide A, Giegling I, et al. "Latent" infection with Toxoplasma gondii: association with trait aggression and impulsivity in healthy adults. J Psychiatr Res 2015;60:87-94.
2. Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation 2013;10:43.
3. Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012;37:137-62.
4. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732-41.
5. Cotter DR, Pariante CM, Everall IP. Glial cell abnormalities in major psychiatric disorders: the evidence and implications. Brain Res Bull 2001;55:585-95.
6. Brietzke E, Stabellini R, Grassi-Oliveira R, Lafer B. Cytokines in bipolar disorder: recent findings, deleterious effects but promise for future therapeutics. CNS Spectr 2011;16:157-68.
7. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008;63:801-8.
8. Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Traskman-Bendz L, Guillemin GJ, et al. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav Immun 2015;43:110-7.
9. Brundin L, Erhardt S, Bryleva EY, Achtyes ED, Postolache TT. The role of inflammation in suicidal behaviour. Acta Psychiatr Scand 2015;132:192-203.
10. Janelidze S, Mattei D, Westrin A, Traskman-Bendz L, Brundin L. Cytokine levels in the blood may distinguish suicide attempters from depressed patients. Brain Behav Immun 2011;25: 335-9.
11. Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011;70:663-71.
12. McNally L, Bhagwagar Z, Hannestad J. Inflammation, glutamate, and glia in depression: a literature review. CNS Spectr 2008;13:501-10.
13. de Witte L, Tomasik J, Schwarz E, Guest PC, Rahmoune H, Kahn RS, et al. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment. Schizophr Res 2014;154:23-9.
14. Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G, et al. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 2000;52:237-41.
15. Ballester J, Goldstein T, Goldstein B, Obreja M, Axelson D, Monk K, et al. Is bipolar disorder specifically associated with aggression? Bipolar Disord 2012;14:283-90.
16. Soyka M. Neurobiology of aggression and violence in schizophrenia. Schizophr Bull 2011;37:913-20.
17. Volavka J, Citrome L. Pathways to aggression in schizophrenia affect results of treatment. Schizophr Bull 2011;37:921-9.
18. Oquendo MA, Galfalvy H, Russo S, Ellis SP, Grunebaum MF, Burke A, et al. Prospective study of clinical predictors of suicidal acts after a major depressive episode in patients with major depressive disorder or bipolar disorder. Am J Psychiatry 2004;161:1433-41.
19. Moeller FG, Barratt ES, Dougherty DM, Schmitz JM, Swann AC. Psychiatric aspects of impulsivity. Am J Psychiatry 2001;158:1783-93.
20. Swann AC, Lijffijt M, Lane SD, Steinberg JL, Moeller FG. Increased trait-like impulsivity and course of illness in bipolar disorder. Bipolar Disord 2009;11:280-8.
21. Suarez EC. Joint effect of hostility and severity of depressive symptoms on plasma interleukin-6 concentration. Psychosom Med 2003;65:523-7.
22. Suarez EC, Lewis JG, Krishnan RR, Young KH. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 2004;29:1119-28.
23. Coccaro EF. Association of C-reactive protein elevation with trait aggression and hostility in personality disordered subjects: a pilot study. J Psychiatr Res 2006;40:460-5.
24. Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiatry 2014;71:158-65.
25. Graham JE, Robles TF, Kiecolt-Glaser JK, Malarkey WB, Bissell MG, Glaser R. Hostility and pain are related to inflammation in older adults. Brain Behav Immun 2006;20:389-400.
26. Bhatt S, Bhatt R, Zalcman SS, Siegel A. Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat. Brain Behav Immun 2008;22:224-33.
27. Patel A, Siegel A, Zalcman SS. Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice. Brain Behav Immun 2010;24:1276-80.
28. Pesce M, Speranza L, Franceschelli S, Ialenti V, Patruno A, Febo MA, et al. Biological role of interleukin-1beta in defensive-aggressive behaviour. J Biol Regul Homeost Agents 2011;25:323-9.
29. Zalcman SS, Siegel A. The neurobiology of aggression and rage: role of cytokines. Brain Behav Immun 2006;20:507-14.
30. Pearce BD, Kruszon-Moran D, Jones JL. The relationship between Toxoplasma gondii infection and mood disorders in the third National Health and Nutrition Survey. Biol Psychiatry 2012;72:290-5.
31. Tedla Y, Shibre T, Ali O, Tadele G, Woldeamanuel Y, Asrat D, et al. Serum antibodies to Toxoplasma gondii and Herpesvidae family viruses in individuals with schizophrenia and bipolar disorder: a case-control study. Ethiop Med J 2011;49:211-20.
32. Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL. Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophr Bull 2012;38:1137-48.
33. Torrey EF, Bartko JJ, Yolken RH. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull 2012;38:642-7.
34. Hinze-Selch D, Daubener W, Erdag S, Wilms S. The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol (Praha) 2010;57:129-35.
35. Arling TA, Yolken RH, Lapidus M, Langenberg P, Dickerson FB, Zimmerman SA, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J Nerv Ment Dis 2009;197:905-8.
36. Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psychiatry 2012;69:1123-30.
37. Ling VJ, Lester D, Mortensen PB, Langenberg PW, Postolache TT. Toxoplasma gondii seropositivity and suicide rates in women. J Nerv Ment Dis 2011;199:440-4.
38. Okusaga O, Langenberg P, Sleemi A, Vaswani D, Giegling I, Hartmann AM, et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr Res 2011;133:150-5.
39. Postolache TT, Cook TB. Is latent infection with Toxoplasma gondii a risk factor for suicidal behavior? Expert Rev Anti Infect Ther 2013;11:339-42.
40. Yagmur F, Yazar S, Temel HO, Cavusoglu M. May Toxoplasma gondii increase suicide attempt-preliminary results in Turkish subjects? Forensic Sci Int 2010;199:15-7.
41. Zhang Y, Traskman-Bendz L, Janelidze S, Langenberg P, Saleh A, Constantine N, et al. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J Clin Psychiatry 2012;73:1069-76.
42. Mann JJ, Arango VA, Avenevoli S, Brent DA, Champagne FA, Clayton P, et al. Candidate endophenotypes for genetic studies of suicidal behavior. Biol Psychiatry 2009;65:556-63.
43. Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci 2005;30:398-408.
44. Kovacsics CE, Gottesman, II, Gould TD. Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annu Rev Pharmacol Toxicol 2009;49:175-98.
45. Flegr J, Kodym P, Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol Psychol 2000;53:57-68.
46. Flegr J, Zitkova S, Kodym P, Frynta D. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 1996;113 (Pt 1):49-54.
47. Flegr J. Effects of toxoplasma on human behavior. Schizophr Bull 2007;33:757-60.
48. Flegr J, Lindova J, Kodym P. Sex-dependent toxoplasmosis-associated differences in testosterone concentration in humans. Parasitology 2008;135:427-31.
49. Lindova J, Novotna M, Havlicek J, Jozifkova E, Skallova A, Kolbekova P, et al. Gender differences in behavioural changes induced by latent toxoplasmosis. Int J Parasitol 2006;36:1485-92.
50. Lindova J, Kubena AA, Sturcova H, Krivohlava R, Novotna M, Rubesova A, et al. Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes. Folia Parasitol (Praha) 2010;57:136-42.
51. Stibbs HH. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol 1985;79:153-7.
52. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One 2011;6:e23866.
53. Xiao J, Li Y, Prandovszky E, Karuppagounder SS, Talbot CC, Jr., Dawson VL, et al. MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience 2014;268:128-38.
54. Martin HL, Alsaady I, Howell G, Prandovszky E, Peers C, Robinson P, et al. Effect of parasitic infection on dopamine biosynthesis in dopaminergic cells. Neuroscience 2015;306:50-62.
55. Webster JP, Lamberton PH, Donnelly CA, Torrey EF. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci 2006;273:1023-30.
56. Skallova A, Kodym P, Frynta D, Flegr J. The role of dopamine in Toxoplasma-induced behavioural alterations in mice: an ethological and ethopharmacological study. Parasitology 2006;133(Pt 5):525-35.
57. Gaskell EA, Smith JE, Pinney JW, Westhead DR, McConkey GA. A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One 2009;4:e4801.
58. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975-90.
59. Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biol Psychol 2003;63:253-68.
60. Novotna M, Hanusova J, Klose J, Preiss M, Havlicek J, Roubalova K, et al. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infect Dis 2005;5:54.
61. Guo G, Roettger ME, Shih JC. Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults. Hum Genet 2007;121:125-36.
62. Yu Q, Teixeira CM, Mahadevia D, Huang Y, Balsam D, Mann JJ, et al. Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice. Mol Psychiatry 2014;19:688-98.
63. Soderstrom H, Blennow K, Manhem A, Forsman A. CSF studies in violent offenders. I. 5-HIAA as a negative and HVA as a positive predictor of psychopathy. J Neural Transm (Vienna) 2001;108:869-78.
64. Schluter T, Winz O, Henkel K, Prinz S, Rademacher L, Schmaljohann J, et al. The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males. J Neurosci 2013;33:16889-96.
65. Chester DS, DeWall CN, Derefinko KJ, Estus S, Lynam DR, Peters JR, et al. Looking for reward in all the wrong places: dopamine receptor gene polymorphisms indirectly affect aggression through sensation-seeking. Soc Neurosci 2016;11:487-94.
66. Zhang-James Y, Faraone SV. Genetic architecture for human aggression: a study of gene-phenotype relationship in OMIM. Am J Med Genet B Neuropsychiatr Genet 2016;171:641-9.
67. Ferrari PF, van Erp AM, Tornatzky W, Miczek KA. Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur J Neurosci 2003;17:371-8.
68. Couppis MH, Kennedy CH. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice. Psychopharmacology (Berl) 2008;197:449-56.
69. Kayser AS, Allen DC, Navarro-Cebrian A, Mitchell JM, Fields HL. Dopamine, corticostriatal connectivity, and intertemporal choice. J Neurosci 2012;32:9402-9.
70. Oswald LM, Wong DF, Zhou Y, Kumar A, Brasic J, Alexander M, et al. Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release. Neuroimage 2007;36:153-66.
71. Schluter T, Winz O, Henkel K, Eggermann T, Mohammadkhani-Shali S, Dietrich C, et al. MAOA-VNTR polymorphism modulates context-dependent dopamine release and aggressive behavior in males. Neuroimage 2016;125:378-85.
72. van Spronsen FJ, Hoeksma M, Reijngoud DJ. Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 2009;32:46-51.
73. Daubner SC, Le T, Wang S. Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 2011;508:1-12.
74. Spellberg B, Edwards JE, Jr. Type 1/Type 2 immunity in infectious diseases. Clin Infect Dis 2001;32:76-102.
75. Neurauter G, Schrocksnadel K, Scholl-Burgi S, Sperner-Unterweger B, Schubert C, Ledochowski M, et al. Chronic immune stimulation correlates with reduced phenylalanine turnover. Curr Drug Metab 2008;9:622-7.
76. Capuron L, Schroecksnadel S, Feart C, Aubert A, Higueret D, Barberger-Gateau P, et al. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol Psychiatry 2011;70:175-82.
77. Werner ER, Blau N, Thony B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 2011;438:397-414.
78. Anderson DN, Wilkinson AM, Abou-Saleh MT, Blair JA. Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation. Acta Psychiatr Scand 1994;90:10-3.
79. Neurauter G, Grahmann AV, Klieber M, Zeimet A, Ledochowski M, Sperner-Unterweger B, et al. Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Lett 2008;272:141-7.
80. Ploder M, Neurauter G, Spittler A, Schroecksnadel K, Roth E, Fuchs D. Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations. Amino Acids 2008;35:303-7.
81. Zangerle R, Kurz K, Neurauter G, Kitchen M, Sarcletti M, Fuchs D. Increased blood phenylalanine to tyrosine ratio in HIV-1 infection and correction following effective antiretroviral therapy. Brain Behav Immun 2010;24:403-8.
82. Hoekstra R, van den Broek WW, Fekkes D, Bruijn JA, Mulder PG, Pepplinkhuizen L. Effect of electroconvulsive therapy on biopterin and large neutral amino acids in severe, medication-resistant depression. Psychiatry Res 2001;103:115-23.
83. Rao ML, Gross G, Strebel B, Braunig P, Huber G, Klosterkotter J. Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Res 1990;34:243-57.
84. Okusaga O, Muravitskaja O, Fuchs D, Ashraf A, Hinman S, Giegling I, et al. Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality? PLoS One 2014;9:e85945.
85. Wei J, Xu H, Ramchand CN, Hemmings GP. Low concentrations of serum tyrosine in neuroleptic-free schizophrenics with an early onset. Schizophr Res 1995;14:257-60.
86. Targum SD, Lang W. Neurobehavioral problems associated with phenylketonuria. Psychiatry (Edgmont) 2010;7:29-32.
87. Wu W, Sheng D, Shao J, Zhao Z. Mental and motor development and psychosocial adjustment of Chinese children with phenylketonuria. J Paediatr Child Health 2011;47:441-7.
88. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR axis I Disorders, research version, Patient Edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute, 2002.
89. Neurauter G, Scholl-Burgi S, Haara A, Geisler S, Mayersbach P, Schennach H, et al. Simultaneous measurement of phenylalanine and tyrosine by high performance liquid chromatography (HPLC) with fluorescence detection. Clin Biochem 2013;46:1848-51.
90. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychol 1957;21:343-9.
91. Hampel R, Selg H. FAF-Fragebogen zur Erfassung von Aggressivitätsfaktoren. Göttingen: Hogrefe, 1975.
92. Okusaga O, Duncan E, Langenberg P, Brundin L, Fuchs D, Groer MW, et al. Combined Toxoplasma gondii seropositivity and high blood kynurenine-Linked with nonfatal suicidal self-directed violence in patients with schizophrenia. J Psychiatr Res 2016;72:74-81.
93. Pappas G, Roussos N, Falagas ME. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 2009;39:1385-94.
94. Coccaro EF, Lee R. Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects. J Neural Transm (Vienna) 2010;117:241-8.
95. House PK, Vyas A, Sapolsky R. Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS One 2011;6:e23277.
96. Coccaro EF, Lee R, Groer MW, Can A, Coussons-Read M, Postolache TT. Toxoplasma gondii infection: relationship with aggression in psychiatric subjects. J Clin Psychiatry 2016;77:334-41.
97. Gatkowska J, Wieczorek M, Dziadek B, Dzitko K, Dlugonska H. Sex-dependent neurotransmitter level changes in brains of Toxoplasma gondii infected mice. Exp Parasitol 2013;133:1-7.
98. Dass SA, Vasudevan A, Dutta D, Soh LJ, Sapolsky RM, Vyas A. Protozoan parasite Toxoplasma gondii manipulates mate choice in rats by enhancing attractiveness of males. PLoS One 2011;6:e27229.
99. Vyas A. Parasite-augmented mate choice and reduction in innate fear in rats infected by Toxoplasma gondii. J Exp Biol 2013;216(Pt 1):120-6.
100. Lim A, Kumar V, Hari Dass SA, Vyas A. Toxoplasma gondii infection enhances testicular steroidogenesis in rats. Mol Ecol 2013;22:102-10.
101. Wurtman RJ, Rose CM, Chou C, Larin FF. Daily rhythms in the concentrations of various amino acids in human plasma. N Engl J Med 1968;279:171-5.